Colonic Neoplasms: Clinical Trials

2,400 trials for Colonic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1204 completed, 416 unknown, 262 recruiting, 217 terminated. 679 Not applicable, 604 Phase 2, 433 Phase 1, 237 Phase 3, 38 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable679Completed 331, Unknown 129, Recruiting 87, Terminated 38, Not yet recruiting 32, Active not recruiting 31, Withdrawn 22, Enrolling by invitation 6, Suspended 3
Phase 2604Completed 292, Unknown 90, Terminated 77, Recruiting 62, Withdrawn 30, Active not recruiting 28, Not yet recruiting 22, Suspended 3
Phase 1433Completed 242, Terminated 64, Recruiting 42, Unknown 37, Active not recruiting 27, Withdrawn 15, Not yet recruiting 3, Suspended 3
Phase 3237Completed 107, Unknown 54, Terminated 26, Recruiting 24, Active not recruiting 15, Not yet recruiting 6, Withdrawn 5
Phase 438Completed 23, Unknown 10, Recruiting 2, Terminated 2, Not yet recruiting 1
Early Phase 126Completed 7, Terminated 6, Withdrawn 4, Active not recruiting 3, Unknown 3, Recruiting 2, Not yet recruiting 1

Follow Colonic Neoplasms: new trials by email Literature Review of Colonic Neoplasms trials Research Report on Colonic Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cancer Awareness Among Syrian Migrants
PMT-Based Cancer Screening Educational Intervention, PMT-Based Cancer Screening Education Program - Breast Cancer Screening, Cervical Cancer Screening
Not applicableNot yet recruitingToros University302027-03-092026-10-15
Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer
Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)] - Colon Cancer
Phase 2Not yet recruitingJohn Strickler, M.D.242027-03-012026-11-05
Collagenase Biobank Study
Colorectal (Colon or Rectal) Cancer
Not yet recruitingUniversity of Chicago1072026-12-012026-10-13
Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal Cancer
varsetatug masetecan, bevacizumab + 5-FU + leucovorin, bevacizumab - Colo-rectal Cancer
Phase 1 / Phase 2Not yet recruitingCytomX Therapeutics3682026-12-012026-10-28
Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach
Colorectal Cancer Education Materials, Cologuard test kit, Fecal immunochemical test kit - Colorectal Cancer (CRC) Screening, CRC Screening
Not applicableNot yet recruitingWashington University School of Medicine2002026-11-302026-11-05
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Pembrolizumab, Porustobart - Colon Cancer
Phase 2RecruitingSolstice Oncology, Inc.1002026-11-302026-11-12
A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors
PF-08165784, Fulvestrant, Atirmociclib - Advanced Breast Cancer, Advanced or Metastatic Breast Cancer
Phase 1Not yet recruitingPfizer2682026-11-092026-10-28
ctDNA and TEP Levels in Colon Cancer
Additional Peripheral Venous Blood Sampling for ctDNA and TEP Biomarker Analysis - Colon Cancer
Not applicableNot yet recruitingInstitute of Oncology Ljubljana802026-11-012026-10-07
T1 Colorectal Cancer After Local Excision: Decision Between Surgery and Active Surveillance (T1LDA Trial)
Additional surgery - Colorectal Cancer
Not applicableNot yet recruitingTampere University Hospital5002026-11-012026-10-28
This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid Tumors
LTZ-232 - Colorectal Cancer, Advanced/Metastatic Solid Tumor
Phase 1RecruitingLTZ Therapeutics, Inc.1522026-10-282026-11-03
A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy
INCA33890 - CRC (Colorectal Cancer)
Phase 2Not yet recruitingIncyte Corporation402026-10-262026-09-22
Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSS
short-course radiotherapy, Serplulimab, CapOx(Capecitabine+ Oxaliplatin) - Locally Advanced Colon Cancer, pMMR
Phase 3Not yet recruitingFudan University4802026-10-152026-10-16
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy Combined With Penpulimab and Fruquintinib for Advanced Colorectal Cancer
Personalized ultrafractionated stereotactic adaptive radiotherapy, Immunotherapy, Target Therapy - Colo-rectal Cancer
Phase 2Not yet recruitingWest China Hospital322026-10-092026-10-29
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Proton Transfer Reaction Mass Spectrometry Analysis - Pancreas Cancer, Hepatocellular Carcinoma
Not yet recruitingUniversity of Oklahoma20002026-10-012026-07-29
Impact of Probiotics on Neuropathy Induced by Adjuvant Chemotherapy in Patients With Colon Cancer.
PROBIOTIC SUPPLEMENTATION BY OXXYSLAB®, PLACEBO supplementation - Colon Adenocarcinoma, Neuropathic Pain
Not applicableNot yet recruitingCentre Francois Baclesse1302026-10-012026-07-30
mFOLFOXIRI Plus PD-1 Inhibitor vs mFOLFOX6 as Neoadjuvant Therapy for Locally Advanced Colon Cancer
cmFOLFOXIRI plus PD-1 inhibitor, mFOLFOX6 - Colon Cancer (Stage II &Amp;Amp; III)
Phase 2Not yet recruitingSun Yat-sen University1382026-10-012026-05-22
A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
Fam-Trastuzumab Deruxtecan-Nxki - Colorectal Cancer, Adenocarcinoma of the Colon
Phase 2Not yet recruitingMemorial Sloan Kettering Cancer Center272026-10-012026-10-01
A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal Cancer
DEM301 - Metastatic Colorectal Cancer, Colon Cancer
Phase 1RecruitingDEM BioPharma, Inc.602026-10-012026-10-28
NURSE-led Geriatric Assessment in Older Colorectal Cancer Patients
Nurse-led Geriatric Assessment - Colo-rectal Cancer
Not applicableNot yet recruitingHelse Stavanger HF502026-09-282026-10-14
Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer
Tafolecimab, Sintilimab - Colon Cancer, PCSK9 Inhibitor
Phase 2RecruitingDaping Hospital and the Research Institute of Surgery of the Third Military Medical University702026-09-202026-09-25

Showing 20 of 2400. Sign in to see all of them.

Narrower conditions

Rectal Neoplasms (836)  ·  Colorectal Neoplasms (830)  ·  Breast Neoplasms (331)  ·  Pancreatic Neoplasms (252)  ·  Lung Neoplasms (220)  ·  Neoplasms (216)  ·  Stomach Neoplasms (199)  ·  Carcinoma, Non-Small-Cell Lung (150)  ·  Neoplasm Metastasis (143)  ·  Prostatic Neoplasms (139)  ·  Ovarian Neoplasms (126)  ·  Esophageal Neoplasms (124)  ·  Melanoma (87)  ·  Carcinoma, Hepatocellular (78)

Broader conditions

Digestive System Diseases (2391)  ·  Intestinal Diseases (2391)  ·  Gastrointestinal Diseases (2388)  ·  Neoplasms by Site (2388)  ·  Digestive System Neoplasms (2384)  ·  Intestinal Neoplasms (2381)  ·  Colonic Diseases (2372)  ·  Gastrointestinal Neoplasms (2340)  ·  Neoplasms (2184)  ·  Colorectal Neoplasms (1570)  ·  Rectal Diseases (1150)  ·  Pathological Conditions, Signs and Symptoms (494)  ·  Skin and Connective Tissue Diseases (363)  ·  Skin Diseases (362)  ·  Neoplasms by Histologic Type (360)

Interventions

Fluorouracil (220)  ·  Leucovorin (203)  ·  Oxaliplatin (192)  ·  Irinotecan (152)  ·  Bevacizumab (112)  ·  Capecitabine (94)  ·  Cetuximab (94)  ·  Folfox protocol (54)  ·  Chemotherapy, Adjuvant (36)  ·  Colonoscopy (30)  ·  Panitumumab (30)  ·  pembrolizumab (26)  ·  Drug Therapy (24)  ·  Magnetic Resonance Spectroscopy (23)  ·  Nivolumab (22)

Sponsors

National Cancer Institute (NCI) (114)  ·  Memorial Sloan Kettering Cancer Center (52)  ·  Alliance for Clinical Trials in Oncology (40)  ·  M.D. Anderson Cancer Center (33)  ·  City of Hope Medical Center (30)  ·  Case Comprehensive Cancer Center (18)  ·  GERCOR - Multidisciplinary Oncology Cooperative Group (18)  ·  Roswell Park Cancer Institute (17)  ·  Assistance Publique - HĂ´pitaux de Paris (16)  ·  Stanford University (16)  ·  Amgen (15)  ·  European Organisation for Research and Treatment of Cancer - EORTC (15)  ·  Fudan University (15)  ·  Sun Yat-sen University (15)  ·  Fox Chase Cancer Center (14)

Countries

United States (1105)  ·  France (211)  ·  China (193)  ·  Italy (132)  ·  Spain (120)  ·  Canada (114)  ·  United Kingdom (107)  ·  Germany (91)  ·  South Korea (84)  ·  Netherlands (68)  ·  Denmark (64)  ·  Belgium (62)  ·  Australia (47)  ·  Taiwan (40)  ·  Israel (37)

Top investigators

Norman Wolmark, MD (12)  ·  Leonard B. Saltz, MD (7)  ·  Shivan Mehta, MD (7)  ·  Nancy E. Kemeny, MD (6)  ·  Aimery de Gramont, MD (5)  ·  Ajay Goel, PhD (5)  ·  Hedy L. Kindler, MD (5)  ·  Howard S. Hochster, MD (5)  ·  Marwan Fakih, MD (5)  ·  Sydney Welt, MD (5)

Results publications

PMID 36306483, PMID 31268130, PMID 33356421, PMID 21997132, PMID 32085892, PMID 35588252, PMID 36657089, PMID 37162250, PMID 37934000, PMID 38564700, PMID 15273542, PMID 15758907, PMID 15894098, PMID 19755046, PMID 22070868, PMID 25071111, PMID 25952085, PMID 26049686, PMID 26348120, PMID 26438146, PMID 27432417, PMID 27986363, PMID 28006055, PMID 28712102, PMID 30466310, PMID 31631858, PMID 31811950, PMID 32702383, PMID 33074326, PMID 33439695, PMID 33538338, PMID 36657661, PMID 37590355, PMID 38315963, PMID 40056080, PMID 40215447, PMID 42100890, PMID 10400410, PMID 10493478, PMID 10496568, PMID 10536559, PMID 10550154, PMID 10615079, PMID 10744089, PMID 11098486, PMID 11114689, PMID 11167863, PMID 11171826, PMID 11247898, PMID 11256129

NIH funding

P30CA033572 (14), P30CA015083 (13), P30CA068485 (12), U10CA031946 (11), P30CA043703 (9), 2019 (8), 2023 (8), 2025 (8), P30CA072720 (7), U10CA032102 (7), 2017 (6), P30CA016672 (6), U10CA012027 (6), U10CA021115 (6), P30CA014089 (5)